Deepali Kumar
Impact in
- Transplantation top 0.2%
- Renal Transplantation Outcomes and Treatments
- Infectious Diseases top 0.2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
- Epidemiology 151
- Cytomegalovirus and herpesvirus research 75
- Influenza Virus Research Studies 36
- Herpesvirus Infections and Treatments 32
- Respiratory viral infections research 25
-
- SARS-CoV-2 and COVID-19 Research 39
- COVID-19 Clinical Research Studies 20
- Co-authors
- Atul Humar (160 shared papers)Lara A. Danziger‐Isakov (15 shared papers)Camille N. Kotton (16 shared papers)Angela M. Caliendo (5 shared papers)Sunwen Chou (3 shared papers)Oriol Manuel (16 shared papers)Shirish S. Huprikar (8 shared papers)Victor H. Ferreira (43 shared papers)
- Journals
- American Journal of Transplantation (55 papers)Transplantation (42 papers)Clinical Infectious Diseases (17 papers)The Journal of Heart and Lung Transplantation (12 papers)The Journal of Infectious Diseases (11 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Deepali Kumar
271 papers receiving 13.6k citations
Deepali Kumar's Hit Papers
Peers
Comparison fields: 5 of 130
- Transplantation 1.2k
- Infectious Diseases 4.5k
- Epidemiology 7.9k
- Hepatology 974
- Oncology 1.5k
Countries citing papers authored by Deepali Kumar
This map shows the geographic impact of Deepali Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deepali Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deepali Kumar more than expected).
Fields of papers citing papers by Deepali Kumar
This network shows the impact of papers produced by Deepali Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deepali Kumar. The network helps show where Deepali Kumar may publish in the future.
Co-authors
The 25 scholars most cited alongside Deepali Kumar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 284 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation Hit paper breakdown → | 2018 | 866 |
| 2 | Anidulafungin versus Fluconazole for Invasive Candidiasis Hit paper breakdown → | 2007 | 714 |
| 3 | Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation Hit paper breakdown → | 2013 | 616 |
| 4 | KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation Hit paper breakdown → | 2020 | 449 |
| 5 | Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients Hit paper breakdown → | 2021 | 422 |
| 6 | Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practice Hit paper breakdown → | 2019 | 329 |
| 7 | 2010 | 316 | |
| 8 | 2009 | 240 | |
| 9 | 2005 | 222 | |
| 10 | Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial Hit paper breakdown → | 2021 | 217 |
| 11 | 2013 | 202 | |
| 12 | 2009 | 197 | |
| 13 | 2015 | 189 | |
| 14 | Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial Hit paper breakdown → | 2021 | 187 |
| 15 | 2020 | 177 | |
| 16 | 2002 | 157 | |
| 17 | 2020 | 147 | |
| 18 | 2011 | 145 | |
| 19 | 2010 | 144 | |
| 20 | 2018 | 141 |
About Deepali Kumar
Deepali Kumar is a scholar working on Epidemiology, Infectious Diseases, Transplantation, Immunology and Hepatology, having authored 284 papers that have together received 14.1k indexed citations. Recurring topics across this work include Cytomegalovirus and herpesvirus research (75 papers), SARS-CoV-2 and COVID-19 Research (39 papers), Influenza Virus Research Studies (36 papers), Herpesvirus Infections and Treatments (32 papers), Respiratory viral infections research (25 papers), Transplantation: Methods and Outcomes (21 papers), COVID-19 Clinical Research Studies (20 papers) and Renal Transplantation Outcomes and Treatments (17 papers). The work is most often cited by research in Transplantation (1.2k citations), Infectious Diseases (4.5k citations), Epidemiology (7.9k citations), Hepatology (974 citations) and Oncology (1.5k citations). Deepali Kumar has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Atul Humar, Lara A. Danziger‐Isakov, Camille N. Kotton, Angela M. Caliendo, Sunwen Chou, Oriol Manuel, Shirish S. Huprikar, Victor H. Ferreira, Anders Åsberg and Coleman Rotstein. Their work appears in journals such as American Journal of Transplantation, Transplantation, Clinical Infectious Diseases, The Journal of Heart and Lung Transplantation and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.